loadpatents
Patent applications and USPTO patent grants for Abou-Gharbia; Magid A..The latest application filed is for "novel functionalized n,n-dialkylamino phenyl ethers and their method of use".
Patent | Date |
---|---|
Functionalized N,N-dialkylamino phenyl ethers and their method of use Grant 11,325,883 - Melenski , et al. May 10, 2 | 2022-05-10 |
Bridged bicycloalkyl-substituted aminothiazoles and their methods of use Grant 10,941,126 - Childers , et al. March 9, 2 | 2021-03-09 |
Novel Functionalized N,n-dialkylamino Phenyl Ethers And Their Method Of Use App 20200392073 - Abou-Gharbia; Magid A. ;   et al. | 2020-12-17 |
Novel Functionalized N,N-Dialkylamino Phenyl Ethers and Their Method of Use App 20200354307 - Melenski; Edward G. ;   et al. | 2020-11-12 |
Beta lactams as modulators of glutamate uptake and methods for use thereof Grant 10,759,750 - Abou-Gharbia , et al. Sep | 2020-09-01 |
Novel Bridged Bicycloalkyl-Substituted Aminothiazoles and Their Methods of Use App 20190352272 - Childers; Wayne C. ;   et al. | 2019-11-21 |
Novel Beta Lactams as Modulators of Glutamate Uptake and Methods for Use Thereof App 20190127323 - Abou-Gharbia; Magid A. ;   et al. | 2019-05-02 |
Cytochrome P450 inhibitors and their method of use Grant 9,725,436 - Blass , et al. August 8, 2 | 2017-08-08 |
Novel Functionalized 5-(phenoxymethyl)-1,3-dioxane Analogs Exhibiting Cytochrome P450 Inhibition And Their Method Of Use App 20160244436 - Blass; Benjamin Eric ;   et al. | 2016-08-25 |
Novel Cytochrome P450 Inhibitors And Their Method Of Use App 20160221990 - Blass; Benjamin Eric ;   et al. | 2016-08-04 |
Novel Functionalized 4-(phenoxymethyl(-1,3-dioxolane Analogs Exhibiting Cytochrome P450 Inhibition And Their Method Of Use App 20150353530 - Blass; Benjamin Eric ;   et al. | 2015-12-10 |
Novel Cytochrome P450 Inhibitors And Their Method Of Use App 20150210641 - Blass; Benjamin Eric ;   et al. | 2015-07-30 |
Method For Treating Nervous System Disorders And Conditions App 20120190721 - Abou-Gharbia; Magid A. ;   et al. | 2012-07-26 |
Method For Treating Nervous System Disorders And Conditions App 20120065240 - Deecher; Darlene Coleman ;   et al. | 2012-03-15 |
Method For Treating Nervous System Disorders And Conditions App 20120010260 - Abou-Gharbia; Magid A. ;   et al. | 2012-01-12 |
Method For Treating Nervous System Disorders And Conditions App 20110124699 - Abou-Gharbia; Magid A. ;   et al. | 2011-05-26 |
Methods For The Treatment And Prevention Of Neurodegenerative Conditions App 20080207631 - Abou-Gharbia; Magid A. ;   et al. | 2008-08-28 |
Ethers of O-desmethyl venlafaxine Grant 7,291,646 - Yardley , et al. November 6, 2 | 2007-11-06 |
Method for treating nervous system disorders and conditions App 20070021488 - Abou-Gharbia; Magid A. | 2007-01-25 |
Method for treating nervous system disorders and conditions App 20060019966 - Deecher; Darlene Coleman ;   et al. | 2006-01-26 |
Method for treating nervous system disorders and conditions App 20060020014 - Abou-Gharbia; Magid A. ;   et al. | 2006-01-26 |
Method for treating nervous system disorders and conditions App 20060020015 - Abou-Gharbia; Magid A. ;   et al. | 2006-01-26 |
Branched adamantyl and noradamantyl aryl- and aralkylpiperazines with serotonin 5-HT1A activity Grant 6,831,084 - Childers, Jr. , et al. December 14, 2 | 2004-12-14 |
Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT1A activity Grant 6,828,324 - Childers, Jr. , et al. December 7, 2 | 2004-12-07 |
Methods for the treatment and prevention of neurodegenerative conditions App 20040192636 - Abou-Gharbia, Magid A. ;   et al. | 2004-09-30 |
Branched adamantyl and noradamantyl aryl-and aralkylpiperazines with serotonin 5-HT 1A activity App 20040162430 - Childers, Wayne E. JR. ;   et al. | 2004-08-19 |
Ethers of o-desmethyl venlafaxine App 20040147601 - Yardley, John P. ;   et al. | 2004-07-29 |
Ethers of O-Desmethyl venlafaxine App 20030158253 - Yardley, John P. ;   et al. | 2003-08-21 |
Methods for the treatment and prevention of neurodegenerative conditions App 20030092753 - Abou-Gharbia, Magid A. ;   et al. | 2003-05-15 |
Ethers of O-Desmethyl venlafaxine App 20020037922 - Yardley, John P. ;   et al. | 2002-03-28 |
Carbamates of rapamycin Grant 5,567,709 - Skotnicki , et al. October 22, 1 | 1996-10-22 |
Carbamates of rapamycin Grant 5,559,112 - Skotnicki , et al. September 24, 1 | 1996-09-24 |
Carbamates of rapamycin Grant 5,532,355 - Skotnicki , et al. July 2, 1 | 1996-07-02 |
Carbamates of rapamycin Grant 5,530,121 - Kao , et al. June 25, 1 | 1996-06-25 |
Carbamates of rapamycin Grant 5,530,007 - Kao , et al. June 25, 1 | 1996-06-25 |
Carbamates of rapamycin Grant 5,508,399 - Kao , et al. April 16, 1 | 1996-04-16 |
Carbamates of rapamycin Grant 5,484,790 - Failli , et al. January 16, 1 | 1996-01-16 |
Carbamates of rapamycin Grant 5,480,988 - Failli , et al. January 2, 1 | 1996-01-02 |
Carbamates of rapamycin Grant 5,480,989 - Kao , et al. * January 2, 1 | 1996-01-02 |
Carbamates of rapamycin Grant 5,434,260 - Skotnicki , et al. July 18, 1 | 1995-07-18 |
Rapamycin oximes and hydrazones Grant 5,378,836 - Kao , et al. January 3, 1 | 1995-01-03 |
Carbamates of rapamycin Grant 5,302,584 - Kao , et al. April 12, 1 | 1994-04-12 |
Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of various central nervous system disorders Grant 5,278,160 - Abou-Gharbia , et al. January 11, 1 | 1994-01-11 |
Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity Grant 5,254,552 - Abou-Gharbia , et al. October 19, 1 | 1993-10-19 |
Antipsychotic quinoline derivatives of benzodioxanmethylamine Grant 5,235,055 - Stack , et al. August 10, 1 | 1993-08-10 |
Psychotropic benzodioxan derivatives Grant 5,126,367 - Stack , et al. June 30, 1 | 1992-06-30 |
Polycyclic phenalkyl amines as psychotropic agents Grant 5,036,070 - Abou-Gharbia July 30, 1 | 1991-07-30 |
Aryl- and heteroaryl piperazinyl carboxamides having central nervous system activity Grant 5,010,078 - Abou-Gharbia , et al. April 23, 1 | 1991-04-23 |
Tertiary alkyl functionalized piperazine derivatives Grant 4,988,814 - Abou-Gharbia , et al. January 29, 1 | 1991-01-29 |
Pyridazino(4,5-b)indolizines Grant 4,985,560 - Sabb , et al. January 15, 1 | 1991-01-15 |
Psychotropic benzisothiazole derivatives Grant 4,968,792 - Stack , et al. November 6, 1 | 1990-11-06 |
Piperazinylalkylcarboxylic acid adamantylamides Grant 4,921,958 - Abou-Gharbia , et al. May 1, 1 | 1990-05-01 |
Fused bicyclic imides with psychotropic activity Grant 4,892,943 - Abou-Gharbia January 9, 1 | 1990-01-09 |
Polycyclic-carbamic acid piperazinoalkyl esters and amides Grant 4,882,432 - Abou-Gharbia , et al. November 21, 1 | 1989-11-21 |
Noradamantyl-carboxylic acid piperazinoalkyl esters Grant 4,873,331 - Childers, Jr. , et al. October 10, 1 | 1989-10-10 |
Polycyclic hydrocarbon succinimides with psychotropic activity Grant 4,804,751 - Abou-Gharbia February 14, 1 | 1989-02-14 |
Histamine H.sub.1 -receptor antagonists Grant 4,766,215 - Abou-Gharbia , et al. August 23, 1 | 1988-08-23 |
Carboline histamine H.sub.1 antagonists Grant 4,754,038 - Abou-Gharbia June 28, 1 | 1988-06-28 |
Psychotropic bicyclic imides Grant 4,748,240 - Stack , et al. May 31, 1 | 1988-05-31 |
Piperazinoisothiazolones with psychotropic activity Grant 4,732,984 - Abou-Gharbia , et al. March 22, 1 | 1988-03-22 |
Pyschotropic polycyclic imides Grant 4,732,983 - Stack , et al. March 22, 1 | 1988-03-22 |
3-Aminoalkyl derivatives of 5,5-disubstituted hydantoins with psychotropic activity Grant 4,675,403 - Abou-Gharbia , et al. June 23, 1 | 1987-06-23 |
2-(substituted piperazinylalkyl).beta.-carbolines useful in treatment of psychological disorders Grant 4,663,456 - Abou-Gharbia May 5, 1 | 1987-05-05 |
Antipsychotic .gamma.-carbolines Grant 4,636,563 - Abou-Gharbia January 13, 1 | 1987-01-13 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.